Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by M&T Bank Corp

M&T Bank Corp lifted its position in Doximity, Inc. (NASDAQ:DOCS) by 6.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,601 shares of the company’s stock after purchasing an additional 543 shares during the quarter. M&T Bank Corp’s holdings in Doximity were worth $459,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Global Retirement Partners LLC boosted its position in shares of Doximity by 468.1% in the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock valued at $29,000 after purchasing an additional 440 shares during the period. UMB Bank n.a. boosted its position in shares of Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after purchasing an additional 235 shares during the period. Farther Finance Advisors LLC boosted its position in shares of Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock valued at $34,000 after purchasing an additional 603 shares during the period. Morse Asset Management Inc acquired a new stake in shares of Doximity in the 3rd quarter valued at about $46,000. Finally, IFP Advisors Inc boosted its position in shares of Doximity by 344.1% in the 4th quarter. IFP Advisors Inc now owns 1,328 shares of the company’s stock valued at $71,000 after purchasing an additional 1,029 shares during the period. 87.19% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares of the company’s stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 37.40% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of analysts recently issued reports on DOCS shares. Leerink Partners raised Doximity from a “market perform” rating to an “outperform” rating and upped their target price for the company from $60.00 to $90.00 in a research report on Friday, February 7th. Leerink Partnrs raised Doximity from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 7th. Mizuho increased their price objective on Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Needham & Company LLC increased their price objective on Doximity from $65.00 to $82.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Finally, Canaccord Genuity Group increased their price objective on Doximity from $60.00 to $71.00 and gave the stock a “hold” rating in a research report on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $64.22.

Doximity Price Performance

DOCS opened at $60.81 on Friday. The business has a 50 day simple moving average of $63.47 and a 200-day simple moving average of $52.31. The stock has a market capitalization of $11.35 billion, a P/E ratio of 60.81, a P/E/G ratio of 4.10 and a beta of 1.34. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $85.21.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.